Bioequivalence Of Zoloft ODT To Jzoloft In Healthy Japanese Subjects
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bioequivalence of Zoloft ODT 50 mg with and
without water to Japanese commercial oral tablet of JZoloft 50 mg under fasting condition
with water in Healthy Japanese Subjects
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.